These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 26729009

  • 1. Economic Evaluation of Concise Cognitive Behavioural Therapy and/or Pharmacotherapy for Depressive and Anxiety Disorders.
    Meuldijk D, Carlier IV, van Vliet IM, van Hemert AM, Zitman FG, van den Akker-van Marle ME.
    J Ment Health Policy Econ; 2015 Dec; 18(4):175-83. PubMed ID: 26729009
    [Abstract] [Full Text] [Related]

  • 2. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
    Health Quality Ontario .
    Ont Health Technol Assess Ser; 2019 Dec; 19(6):1-199. PubMed ID: 30873251
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness and cost-utility of an Acceptance and Commitment Therapy intervention vs. a Cognitive Behavioral Therapy intervention for older adults with anxiety symptoms: A randomized controlled trial.
    Witlox M, Kraaij V, Garnefski N, Bohlmeijer E, Smit F, Spinhoven P.
    PLoS One; 2022 Dec; 17(1):e0262220. PubMed ID: 35081130
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of blended vs. face-to-face cognitive behavioural therapy for severe anxiety disorders: study protocol of a randomized controlled trial.
    Romijn G, Riper H, Kok R, Donker T, Goorden M, van Roijen LH, Kooistra L, van Balkom A, Koning J.
    BMC Psychiatry; 2015 Dec 12; 15():311. PubMed ID: 26651478
    [Abstract] [Full Text] [Related]

  • 5. START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of carers of people with dementia.
    Livingston G, Barber J, Rapaport P, Knapp M, Griffin M, Romeo R, King D, Livingston D, Lewis-Holmes E, Mummery C, Walker Z, Hoe J, Cooper C.
    Health Technol Assess; 2014 Oct 12; 18(61):1-242. PubMed ID: 25300037
    [Abstract] [Full Text] [Related]

  • 6. The clinical effectiveness of concise cognitive behavioral therapy with or without pharmacotherapy for depressive and anxiety disorders; a pragmatic randomized controlled equivalence trial in clinical practice.
    Meuldijk D, Carlier IV, van Vliet IM, van Veen T, Wolterbeek R, van Hemert AM, Zitman FG.
    Contemp Clin Trials; 2016 Mar 12; 47():131-8. PubMed ID: 26762883
    [Abstract] [Full Text] [Related]

  • 7. Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up.
    Romijn G, Batelaan N, Koning J, van Balkom A, de Leeuw A, Benning F, Hakkaart van Roijen L, Riper H.
    PLoS One; 2021 Mar 12; 16(11):e0259493. PubMed ID: 34767575
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of childhood anxiety disorder in the context of maternal anxiety disorder: a randomised controlled trial and economic analysis.
    Creswell C, Cruddace S, Gerry S, Gitau R, McIntosh E, Mollison J, Murray L, Shafran R, Stein A, Violato M, Voysey M, Willetts L, Williams N, Yu LM, Cooper PJ.
    Health Technol Assess; 2015 May 12; 19(38):1-184, vii-viii. PubMed ID: 26004142
    [Abstract] [Full Text] [Related]

  • 11. Economic evaluation of mindfulness group therapy for patients with depression, anxiety, stress and adjustment disorders compared with treatment as usual.
    Saha S, Jarl J, Gerdtham UG, Sundquist K, Sundquist J.
    Br J Psychiatry; 2020 Apr 12; 216(4):197-203. PubMed ID: 30468136
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder: A Health Technology Assessment.
    Health Quality Ontario .
    Ont Health Technol Assess Ser; 2017 Apr 12; 17(15):1-167. PubMed ID: 29213344
    [Abstract] [Full Text] [Related]

  • 15. Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.
    Richards DA, Rhodes S, Ekers D, McMillan D, Taylor RS, Byford S, Barrett B, Finning K, Ganguli P, Warren F, Farrand P, Gilbody S, Kuyken W, O'Mahen H, Watkins E, Wright K, Reed N, Fletcher E, Hollon SD, Moore L, Backhouse A, Farrow C, Garry J, Kemp D, Plummer F, Warner F, Woodhouse R.
    Health Technol Assess; 2017 Aug 12; 21(46):1-366. PubMed ID: 28857042
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The cost-effectiveness of short-term psychodynamic psychotherapy and solution-focused therapy in the treatment of depressive and anxiety disorders during a one-year follow-up.
    Maljanen T, Paltta P, Harkanen T, Virtala E, Lindfors O, Laaksonen MA, Knekt P, Helsinki Psychotherapy Study Group.
    J Ment Health Policy Econ; 2012 Mar 12; 15(1):13-23. PubMed ID: 22611089
    [Abstract] [Full Text] [Related]

  • 19. Economic evaluation of stepped-care versus usual care for depression and anxiety in older adults with vision impairment: randomized controlled trial.
    van der Aa HPA, van Rens GHMB, Bosmans JE, Comijs HC, van Nispen RMA.
    BMC Psychiatry; 2017 Aug 01; 17(1):280. PubMed ID: 28764679
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.